Focal boosted IMRT treatment of prostate cancer to 84 Gy in 28 fractions: preliminary clinical outcomes, toxicity, and dosimetry
{{output}}
Introduction: The FLAME trial reported that focal boosting of prostate tumors up to 95 Gy in 35 fractions improves biochemical control (disease-free survival). However, this treatment (regimen) is not commonly used in the United ... ...
